Gene therapy

FILE - In this Feb. 14, 2019, file photo, Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma speaks during a news conference in Washington. Expanding access to a promising but costly treatment, Medicare said Aug. 7, it will cover for some blood cancers a breakthrough gene therapy that revs up a patient’s own immune cells to destroy malignancies. Verma said the decision will provide consistent and predictable access nationwide, opening up treatment options for some patients "who had nowhere else to turn." (AP Photo/Kevin Wolf, File)
August 07, 2019 - 3:44 pm
WASHINGTON (AP) — Expanding access to a promising but costly treatment, Medicare said Wednesday it will cover for some blood cancers a breakthrough gene therapy that revs up a patient's own immune cells to destroy malignancies. Officials said Medicare will cover CAR-T cell therapies for certain...
Read More
In this June 20, 2019 photo, the Capitol is seen from the roof of the Canadian Embassy in Washington. Health care is on the agenda for Congress when lawmakers return, and it’s not another battle over the Obama-era Affordable Care Act. Instead of dealing with the uninsured, lawmakers are trying to bring down costs for people who already have coverage. (AP Photo/J. Scott Applewhite)
July 07, 2019 - 6:00 am
WASHINGTON (AP) — Lawmakers are trying to set aside their irreconcilable differences over the Obama-era Affordable Care Act and work to reach bipartisan agreement on a more immediate health care issue, lowering costs for people who already have coverage. Returning from their Fourth of July recess,...
Read More
May 24, 2019 - 10:41 am
U.S. regulators have approved the most expensive medicine ever, a therapy meant to cure a disorder that rapidly destroys a baby's muscle control and kills most within a couple years. The one-time gene therapy developed by Novartis, Zolgensma (zohl-JEN-smah), will cost $2.125 million. It treats a...
Read More
February 25, 2019 - 11:40 am
Stocks marched higher on Wall Street Monday after President Donald Trump agreed to hold off on raising tariffs on Chinese goods, which would have escalated a damaging trade war between the world's two largest economies. Investors had been growing increasingly optimistic over the last two weeks that...
Read More
In this Monday, Aug. 13, 2018 photo, Brian Madeux interacts with research nurse Chrishauna Lacy at his home in New River, Ariz. Madeux was the first person in the world to participate in a gene editing attempt in his body, for the inherited disease Hunter syndrome. Early partial results from the study were released on Wednesday, Sept. 5, 2018. (AP Photo/Matt York)
September 05, 2018 - 5:58 am
PHOENIX (AP) — Early, partial results from a historic gene editing study give encouraging signs that the treatment may be safe and having at least some of its hoped-for effect, but it's too soon to know whether it ultimately will succeed. The results announced Wednesday are from the first human...
Read More
FILE - In this Monday, Nov. 13, 2017 file photo, a nurse practitioner prepares to start the first human gene editing treatment for Hunter syndrome, an inherited metabolic disease, at a hospital in Oakland, Calif. On Wednesday, Aug. 15, 2018, federal officials said that gene therapy is becoming an established form of medical care and carries no special risks that warrant special regulation, as they revised rules for vetting such experiments and products. (AP Photo/Eric Risberg)
August 15, 2018 - 3:57 pm
U.S. health officials are eliminating special regulations for gene therapy experiments, saying that what was once exotic science is quickly becoming an established form of medical care with no extraordinary risks. A special National Institutes of Health oversight panel will no longer review all...
Read More